Inhaled medications for chronic obstructive pulmonary disease predict surgical complications and survival in stage I non-small cell lung cancer.

Authors:
Tohmasi S; Eaton DB; Heiden BT; Rossetti NE; Rasi V and 8 more

Journal:
J Thorac Dis

Publication Year: 2023

DOI:
10.21037/jtd-23-1273

PMCID:
PMC10797395

PMID:
38249867

Journal Information

Full Title: J Thorac Dis

Abbreviation: J Thorac Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Respiratory System

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1273/coif). S.T. was supported in part by the Washington University School of Medicine (WUSM) Surgical Oncology Basic Science and Translational Research Training Program grant T32CA009621 from the NCI. B.T.H. has funding through NIH Grant 5T32HL007776-25, is a former consultant at Oncocyte Corporation, and is an MBA intern (at Eli Lilly and Company). N.E.R. was supported by the WUSM StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training R38 CA 255575. V.R. was supported through a NHLBI F30 F30HL151136 grant. B.D.K. was supported in part by NCI Grant R01CA258681. V.P. has received the following grants for projects: I01 HX002475, R01HL146856, R01CA258681, MATF and has funding through VHA Grant 1I01HX002475-01A2. V.P. has also received speaking fees from PrecisCa and his spouse has stock in Intuitive Surgical. S.H.C., Y.Y., and D.B.E. have funding through VHA Grant 1I01HX002475-01A2. M.W.S. has funding through the Congressionally Directed Medical Research Program DoD W81XWH-22-1-0602 and received speaking fees from Pfizer. The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported in part by the Washington University School of Medicine (WUSM) Surgical Oncology Basic Science and Translational Research Training Program grant T32CA009621 from the NCI (to S.T.), NIH Grant 5T32HL007776-25 (to B.T.H.), the WUSM StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training R38 CA 255575 (to N.E.R.), NHLBI F30 F30HL151136 grant (to V.R.), NCI Grant R01CA258681 (to B.D.K.), VHA Grant 1I01HX002475-01A2 (to V.P., S.H.C., Y.Y., and D.B.E.) and the Congressionally Directed Medical Research Program DoD W81XWH-22-1-0602 (to M.W.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the VHA, DoD, or NIH."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025